TRXB
TRex Bio, Inc. · NASDAQ:TRXB
13.74 USD0.2200 +1.63%
TRex Bio, Inc. (NASDAQ:TRXB) last traded at 13.74 USD, up 1.63% on the day. Over the past year the stock is up 1.78%. Its 52-week range is 13.10 to 16.56. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open13.66
Day range13.10 – 13.86
52-week range13.10 – 16.56
Volume39.18 K
Average volume (10 days)66.53 K
Market cap377.10 M
Dividend yield0.00%
Beta (1 year)−0.7600
Performance
−10.72%1 week
+1.78%1 month
+1.78%3 months
+1.78%6 months
+1.78%Year to date
+1.78%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Wedbush initiates coverage of Trex Bio at Outperform, sets price target at $30TradingView · 02 Nov 2026
- Catalyst watch: Election drama, jobs report, Apple and McDonald's in the earnings confessionalSeeking Alpha · 30 Oct 2026
- Eli Lilly Discloses Investment at TRex Bio with 19.9% StakeTradingView · 16 Oct 2026
- Trexbio Announces Closing Of Initial Public OfferingReuters · 13 Oct 2026
- TRex Bio, Inc. (TRXB) Closes $116.7M IPO at $14TradingView · 13 Oct 2026
- TRexBio Announces Closing of Initial Public OfferingGlobeNewswire · 13 Oct 2026
- Eli Lilly-backed TRex Bio closes day flat after IPOSeeking Alpha · 09 Oct 2026
- TRex Bio IPO Priced at Bottom of ExpectationsDow Jones Newswires · 09 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.